Intralesional Therapy for Melanoma Effective, May Have Systemic Activity

MedPage Today) — CHICAGO — Preoperative intralesional treatment with a dual antibody-cytokine fusion significantly improved relapse-free survival (RFS) in locally advanced melanoma versus surgery alone, a randomized trial showed.
Median RFS…

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button